Dynavox Group (DYVOX) Q3 2025 earnings summary

Executive summary

• Revenue grew 35% year-over-year in local currencies to SEK 606 million, with especially strong performance in direct presence markets outside North America and robust growth among younger autism users and eye gaze-controlled solutions.

• Strategic investments in ERP rollout and consolidation of product development in Stockholm are progressing as planned.

• Major acquisitions in Germany (RehaMedia) and France (Cenomy) were completed, expanding direct market presence.

• Profitability was temporarily impacted by SEK 26 million in non-recurring costs, lowering the EBIT margin to 10.6%.

• Basic EPS was SEK 0.36, down from SEK 0.43 last year.

Financial highlights

• Q3 2025 revenue reached SEK 606 million, with 33% organic growth and 35% currency-adjusted growth; gross margin improved to 70%.

• EBIT was SEK 64 million (10.6% margin), including SEK 26 million in non-recurring costs.

• Cash flow after investments was SEK 20 million; cash at quarter-end was SEK 172 million.

• Net debt was SEK 924 million; net debt/EBITDA LTM was 2.0.

• Unused revolving credit facility: SEK 300 million.

Outlook and guidance

• Management expects continued strong growth in an underpenetrated market, supported by long-term investments in ERP and organizational centralization.

• Strategic investments and non-recurring costs are expected to decrease after 2025.

• Q4 is expected to be the strongest quarter due to seasonality, with no change in the typical pattern.

• Financial targets remain: 20% average annual revenue growth (currency-adjusted) and EBIT margin to reach/exceed 15% over 3–4 years.

• No immediate risks from U.S. government shutdown or changes to funding systems; ongoing monitoring continues.